Literature DB >> 8990200

The choroid plexus epithelium is the site of the organic anion transport protein in the brain.

R H Angeletti1, P M Novikoff, S R Juvvadi, J M Fritschy, P J Meier, A W Wolkoff.   

Abstract

The mRNA for organic anion transport protein (oatp) was previously shown to be present in abundance in liver and kidney, and in small amounts in brain. Data obtained from experiments with reverse transcriptase-PCR techniques and in situ hybridization analysis showed that the oatp mRNA is present within the brain, localized to the choroid plexus. A sequence-specific antibody to the oatp polypeptide demonstrated the presence of the expected polypeptide with a molecular weight of 80,000 plus an immunoreactive species with a higher molecular weight in preparations of choroid plexus membranes. Examination of the choroid plexus by fluorescence confocal microscopy revealed that immunoreactive oatp polypeptide is localized to the apical surface of the choroid plexus epithelial cells, which contacts the cerebrospinal fluid. This localization of oatp is consistent with previous experiments showing vectorial transport of organic anions between the choroid plexus and the cerebrospinal fluid.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 8990200      PMCID: PMC19316          DOI: 10.1073/pnas.94.1.283

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  21 in total

1.  Active transport of Diodrast and phenolsulfonphthalein from cerebrospinal fluid to blood.

Authors:  J R PAPPENHEIMER; S R HEISEY; E F JORDAN
Journal:  Am J Physiol       Date:  1961-01

2.  Secretory activity of the chorioid plexus in tissue culture.

Authors:  G CAMERON
Journal:  Anat Rec       Date:  1953-09

3.  Immunologic distribution of an organic anion transport protein in rat liver and kidney.

Authors:  A J Bergwerk; X Shi; A C Ford; N Kanai; E Jacquemin; R D Burk; S Bai; P M Novikoff; B Stieger; P J Meier; V L Schuster; A W Wolkoff
Journal:  Am J Physiol       Date:  1996-08

4.  Identification of the cationic amino acid transporter (System y+) of the rat blood-brain barrier.

Authors:  J Stoll; K C Wadhwani; Q R Smith
Journal:  J Neurochem       Date:  1993-05       Impact factor: 5.372

5.  Expression cloning of a rat liver Na(+)-independent organic anion transporter.

Authors:  E Jacquemin; B Hagenbuch; B Stieger; A W Wolkoff; P J Meier
Journal:  Proc Natl Acad Sci U S A       Date:  1994-01-04       Impact factor: 11.205

6.  Identification and characterization of a prostaglandin transporter.

Authors:  N Kanai; R Lu; J A Satriano; Y Bao; A W Wolkoff; V L Schuster
Journal:  Science       Date:  1995-05-12       Impact factor: 47.728

7.  Biphasic differential changes of GABAA receptor subunit mRNA levels in dentate gyrus granule cells following recurrent kindling-induced seizures.

Authors:  M Kokaia; G D Pratt; E Elmér; J Bengzon; J M Fritschy; Z Kokaia; O Lindvall; H Mohler
Journal:  Brain Res Mol Brain Res       Date:  1994-06

8.  Transfer of bilirubin covalently bound to 125I-albumin from blood to brain in the Gunn rat newborn.

Authors:  M Ohsugi; H Sato; H Yamamura
Journal:  Biol Neonate       Date:  1992

9.  Sodium-dependent nucleoside transport in choroid plexus from rabbit. Evidence for a single transporter for purine and pyrimidine nucleosides.

Authors:  X Wu; G Yuan; C M Brett; A C Hui; K M Giacomini
Journal:  J Biol Chem       Date:  1992-05-05       Impact factor: 5.157

10.  Three-dimensional organization of rat hepatocyte cytoskeleton: relation to the asialoglycoprotein endocytosis pathway.

Authors:  P M Novikoff; M Cammer; L Tao; H Oda; R J Stockert; A W Wolkoff; P Satir
Journal:  J Cell Sci       Date:  1996-01       Impact factor: 5.285

View more
  24 in total

1.  Demonstration of a coupled metabolism-efflux process at the choroid plexus as a mechanism of brain protection toward xenobiotics.

Authors:  N Strazielle; J F Ghersi-Egea
Journal:  J Neurosci       Date:  1999-08-01       Impact factor: 6.167

Review 2.  Hepatocellular transport proteins and their role in liver disease.

Authors:  C Stanca; D Jung; P J Meier; G A Kullak-Ublick
Journal:  World J Gastroenterol       Date:  2001-04       Impact factor: 5.742

Review 3.  The impact of efflux transporters in the brain on the development of drugs for CNS disorders.

Authors:  Eve M Taylor
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

Review 4.  Considerations in the use of cerebrospinal fluid pharmacokinetics to predict brain target concentrations in the clinical setting: implications of the barriers between blood and brain.

Authors:  Elizabeth C M de Lange; Meindert Danhof
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

Review 5.  The role of P-glycoprotein and organic anion-transporting polypeptides in drug interactions.

Authors:  Lawrence M DuBuske
Journal:  Drug Saf       Date:  2005       Impact factor: 5.606

Review 6.  Transporters at CNS barrier sites: obstacles or opportunities for drug delivery?

Authors:  Lucy Sanchez-Covarrubias; Lauren M Slosky; Brandon J Thompson; Thomas P Davis; Patrick T Ronaldson
Journal:  Curr Pharm Des       Date:  2014       Impact factor: 3.116

Review 7.  Vectorial ligand transport through mammalian choroid plexus.

Authors:  Reynold Spector; Conrad E Johanson
Journal:  Pharm Res       Date:  2010-05-15       Impact factor: 4.200

8.  Effect of probenecid on fluorescein transport in the central nervous system using in vitro and in vivo models.

Authors:  H Sun; D W Miller; W F Elmquist
Journal:  Pharm Res       Date:  2001-11       Impact factor: 4.200

Review 9.  Drug transporters in the central nervous system.

Authors:  Bruno Stieger; Bo Gao
Journal:  Clin Pharmacokinet       Date:  2015-03       Impact factor: 6.447

Review 10.  SLC and ABC Transporters: Expression, Localization, and Species Differences at the Blood-Brain and the Blood-Cerebrospinal Fluid Barriers.

Authors:  Marilyn E Morris; Vivian Rodriguez-Cruz; Melanie A Felmlee
Journal:  AAPS J       Date:  2017-06-29       Impact factor: 4.009

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.